Company page

Kalvista Pharmaceuticals, Inc.

Kalvista Pharmaceuticals, Inc. (Ticker: KALV) is a public company based in the United States, focused on developing innovative treatments for eye diseases and other conditions. With a market capitalization of approximately $1.43 billion, Kalvista is committed to advancing its pipeline of pharmaceutical products. The company aims to address unmet medical needs through its research and development efforts.